84 related articles for article (PubMed ID: 20818602)
1. The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma.
Zhang XY; Dong QG; Huang JS; Huang AM; Shi CL; Jin B; Sha HF; Feng JX; Geng Q; Zhou J; Xu HL; Han BH
J Surg Oncol; 2010 Dec; 102(7):856-62. PubMed ID: 20818602
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of OCT4 expression in adenocarcinoma of the lung.
Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q
Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980
[TBL] [Abstract][Full Text] [Related]
3. [Lung adenocarcinoma stem cell phenotypes and their correlation with patient prognosis].
Zhang XY; Zheng BQ; Han BH; Huang JS; Geng Q; Xu HL; Zhou J; Dong QG
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):836-40. PubMed ID: 20137348
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
5. shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis.
Meng X; Wang Y; Zheng X; Liu C; Su B; Nie H; Zhao B; Zhao X; Yang H
Lung Cancer; 2012 Jul; 77(1):24-30. PubMed ID: 22420951
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Bmi-1 protein in bladder cancer].
Qin ZK; Yang JA; Zeng MS; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Chen ZF
Ai Zheng; 2008 Dec; 27(12):1327-30. PubMed ID: 19080003
[TBL] [Abstract][Full Text] [Related]
7. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.
Zhang X; Sun J; Wang H; Lou Y; Zhang Y; Sha H; Feng J; Han B
Tumour Biol; 2014 Jan; 35(1):739-45. PubMed ID: 23990442
[TBL] [Abstract][Full Text] [Related]
8. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
10. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
11. [Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma].
Zhang X; Wang H; Jin B; Dong Q; Huang J; Han B
Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):197-202. PubMed ID: 23601300
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
13. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
14. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.
Arnes JB; Collett K; Akslen LA
Histopathology; 2008 Feb; 52(3):370-80. PubMed ID: 18269588
[TBL] [Abstract][Full Text] [Related]
16. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
Zhang F; Sui L; Xin T
Exp Oncol; 2008 Mar; 30(1):70-4. PubMed ID: 18438345
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma.
Sato G; Saijo Y; Uchiyama B; Kumano N; Sugawara S; Fujimura S; Sato M; Sagawa M; Ohkuda K; Koike K; Minami Y; Satoh K; Nukiwa T
J Clin Oncol; 1999 Sep; 17(9):2721-7. PubMed ID: 10561346
[TBL] [Abstract][Full Text] [Related]
18. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
